SOLICITATION NOTICE
65 -- Nerve_Block_Trays - QSL FBO Package Worksheet
- Notice Date
- 5/4/2015
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 339113
— Surgical Appliance and Supplies Manufacturing
- Contracting Office
- Defense Logistics Agency, DLA Acquisition Locations, DLA Troop Support - Medical, 700 Robbins Avenue, Philadelphia, Pennsylvania, 19111-5096, United States
- ZIP Code
- 19111-5096
- Solicitation Number
- ME-1408-16
- Point of Contact
- Mr. Tom Winkel, Phone: 011-49-6371-9464-4089, Ms. Gabrielle Burns, Phone: 011-49-6371-9464-4933
- E-Mail Address
-
thomas.p.winkel.ctr@mail.mil, gabrielle.m.burns2.ctr@mail.mil
(thomas.p.winkel.ctr@mail.mil, gabrielle.m.burns2.ctr@mail.mil)
- Small Business Set-Aside
- N/A
- Description
- Complete answers and all supporting documentation must be provided with the vendor’s submittal by the response date stated in the QSL FBO Sources Sought notification. A vendor who does not meet all of these requirements or who does not submit documentation to support these requirements as requested will not be qualified for the QSL. Vendor must provide responses to the Sources Sought notification via the QSL FBO Package Worksheet. The Defense Health Agency (DHA) Medical Logistics (MEDLOG) Division Medical Materiel Enterprise Standardization Office (MMESO) and the Defense Logistics Agency (DLA) Troop Support Medical Prime Vendor (PV) Program announce a Sources Sought Notification for the creation of a Qualified Suppliers Listing (QSL) for Nerve Block Trays. This is not a request for quote or proposal. The MMESO Europe is the lead MMESO for this project. These Nerve Block Tray products are for purchase by the Military Treatment Facilities (MTFs) of the Military Health System (MHS) and for the operational assemblages of the Army, Navy, Air Force, Marine Corps, and Naval Expeditionary Medical Support Command (NEMSCOM) and managed regionally by MMESOs North, South, West, Pacific and Europe, hereafter referred to as MMESOs. For information regarding DLA Troop Support Medical's PV program please access its web site at https://www.medical.dla.mil. This Sources Sought notification is intended to solicit information and products for evaluation in order to create a QSL in accordance with (IAW) FAR 9.2 for Nerve Block Trays. All items proposed to be included in this QSL must be on a Distribution and Pricing Agreement (DAPA) for the DLA Troop Support Medical/Surgical Prime Vendor (MSPV) Program. All participating vendors must complete the certification in the DAPA Management System (DMS). The MSPV Program requires that all items be manufactured in a Trade Agreements Act (TAA) Compliant Country (as defined by FAR 52.225-5), unless it is determined that no functionally equivalent item is available from a compliant source. Any questions concerning TAA may be directed to Maryann DiMeo at DLA Troop Support, maryann.dimeo@dla.mil, 215-737-3201. The QSL for Nerve Block Trays will be established approximately October 2015 and is anticipated to be the basis of a Standardization Action. Qualified vendors will be invited approximately November 2015 to submit pricing proposals to enter into an Incentive Agreement for Nerve Block Trays. The government reserves the right to standardize or not standardize on Nerve Block Trays. A. Products & Performance Required. The MMESOs are seeking product line items in the category of Nerve Block Trays. Within the MHS MTFs and operational procurement this product line has an estimated annual sales volume of $303,733. This forecast is based on historical usage data during a recent 12-month period. Six items are required for addition to the QSL and account for 72.55%% ($220,381) of the total volume in sales ($303,733). The specifications for this project are shown in "Requirements to Qualify for QSL" section below. B. Instructions to Vendors Vendors interested in qualifying for inclusion in the QSL must provide an e-mail response to this QSL FBO Sources Sought notification to the lead MMESO POCs below. The vendor's responses must include all detailed information requested in the "Requirements to Qualify for QSL" section below and must also include: (1) Company name and address; (2) Company POC (Name and Phone Number, Fax Number, and E-mail address); (3) Commercial and Government Entity (CAGE) Code; and (4) Identification of the Sources Sought notification to which the vendor is responding. Due to the potential for e-mail to be lost in transmission, from network security, etc., vendors are strongly encouraged to confirm with the lead MMESO that their e-mail submission has arrived. Each submitting vendor is advised to confirm receipt, allowing adequate time for resubmission before the due date and time should a problem occur with the first submission. As part of the "Requirements to Qualify for QSL", vendors must complete and submit the QSL FBO Package Worksheet. Any vendor experiencing difficulty opening the Worksheet may contact the MMESO POCs. The MMESO POC will provide a Worksheet copy via an alternate method (fax, email or hard copy). Vendors that do not meet the deadline of COB 5:00 PM Eastern Standard Time (EST) on the date listed for closing in this QSL FBO Sources Sought notification will not be included in the lead MMESO's review to establish the instant QSL and thus will not be able to participate in the subsequent Standardization Action. C. Source Selection Procedures The MMESO Joint Product Review Board (JPRB) will serve as the forum for clinical recommendations for product selection and coordinate logistics efforts in support of DoD Components. The board is chaired by Designated Senior Logisticians (DSLs) and co-chaired by Designated Senior Clinicians (DSCs) in the MMESO Areas of Responsibility (AORs) and includes clinicians and logisticians for MTFs within each MMESO. The Clinical Advisory Committee (CAC) members are the deciding officials for this initiative. The MMESO DSLs and DSCs intend to review responses and evaluate products for selection to the QSL IAW FAR 9.2. Requirements to Qualify for QSL The requirements for this product line are outlined below. Complete answers and all supporting documentation must be provided with the vendor's submittal by the response date stated in this QSL FBO Sources Sought notification. A vendor who does not meet all of these requirements or who does not submit documentation to support these requirements as requested will not be qualified for the QSL. Vendors must provide responses to this Sources Sought notification via the QSL FBO Package Worksheet. 1. Vendor must have a DAPA or be in the process of applying for a DAPA number for the product line listed. Vendor must provide their DAPA number or provide documentation and date the DAPA number was applied for. Vendors who do not continue to process application for a DAPA number will not be considered for continued participation. 2. Vendor must have an agreement with the current DoD Medical/Surgical Prime Vendor CARDINAL HEALTH, or must work with CARDINAL HEALTH to initiate an agreement. 3. Vendor must have an agreement with the current DoD Medical/Surgical Prime Vendor OWENS & MINOR, or must work with OWENS & MINOR to initiate an agreement. 4. Vendor must have a government issued Commercial and Government Entity (CAGE) code assigned for products contained within the specific product group or be in the process of obtaining one. Vendors must validate that their account is Active in the System for Award Management (SAM) and provide CAGE Code. Vendors in the process of obtaining a CAGE Code must provide documentation to support that they have registered in SAM. Vendors who do not continue to process application for a CAGE Code and/or a SAM account will not be considered for continued participation. See https://www.sam.gov/portal/public/SAM/. 5. Vendor must provide product catalog & literature for any items offered in response to this Sources Sought Notification. Vendor must submit the following information via QSL FBO Package Worksheet for each offered product: Full item description, Distributor Part Number, Manufacturer Part Number, Manufacturer Name, and Number of eaches in Unit of Sale. Only ONE Vendor Part Number (PN) should be provided for each item/sample. Required Products / Annual Usage in Units / a. Nerve Block Support Tray- Chronic Pain / 9650 / At MINIMUM, the tray must have the following components: / One: 18 ga x 38-40mm nonsafety Hypodermic Needle / One: 25 ga x 25-51mm nonsafety Hypodermic Needle / One: 2-3ml Luer Lock Syringe / One: 10ml Luer Lock Syringe / One: Paper Towel (minimum dimensions 13inl x 18inl) / One: 1% Lidocaine HCl Solution in 5ml / Minimum of Four: 3inl x 3inl or 4inl x 4inl gauze pads / One: Needle disposal safety device / One: Chlorhexidine gluconate 2% and Isopropyl alcohol 70% in 3ml applicator / One: 22-26inl x 28-32inl clear drape with a minimum 4inl x 4inl or a 4inl circular fenestration and adhesive / Medication Labels / b. Nerve Block Support Tray - Acute Pain / 1020 / At MINIMUM, the tray must have the following components: / One: 18 ga x 38-40mm nonsafety Hypodermic Needle / One: 25 ga x 25-51mm nonsafety Hypodermic Needle / One: 1% Lidocaine HCl Solution in 5ml (must come with one filter straw if medication is in a glass ampule) / Minimum of Four: 3inl x 3inl or 4inl x 4inl gauze pads / One: Needle disposal safety device / One: Chlorhexidine gluconate 2% and Isopropyl alcohol 70% in 3ml applicator / One: 22-26inl x 28-32inl clear drape with a minimum 4inl x 5inl fenestration and adhesive / One: 20ml Luer Lock Syringe / Medication Labels / c. Continuous Nerve Block Tray - Stimulating Needle and NON-Stimulating Catheter / 50 / At MINIMUM, the tray must have the following components: / One: 17 ga or 18 ga x 90-100mm Stimulating Nerve Block Needle / One: 18 ga x 38-40mm nonsafety Hypodermic Needle / One: 25 ga x 25-51mm nonsafety Hypodermic Needle / One: 3 ml or 5 ml Luer Lock Syringe / One: 19 ga or 20 ga x 55-60cm continuous non-stimulating nerve block catheter / One: 1% Lidocaine HCl Solution in 5ml (must come with one filter straw if medication is in a glass ampule) // One: 22-26inl x 28-32inl clear drape with a minimum 4inl x 5inl or a 4inl circular fenestration and adhesive One: Chlorhexidine gluconate 2% and Isopropyl alcohol 70% in 3ml applicator / One: 18-28inl Extension tubing / One: Transparent dressing minimum: 3.75inl x 4.5inl / One: Needle sharps device / Minimum of Four: 4inl x 4inl gauze pads / Medication labels / One: 20 ml Luer Lock Syringe / One: Adapter connector / d. 17 ga or 18 ga x 90mm-100mm Nerve Block Kit - Stimulating Needle and NON-Stimulating Catheter / 1140 / At MINIMUM, the tray must have the following components: / One: 17 ga or 18 ga x 90-100mm Tuohy Needle, Stimulating / One: 20 ga x 24-39inl (61-100cm) Catheter / One: Catheter connector / e. 17 ga or 18 ga x 150mm Nerve Block Kit - Stimulating Needle and NON-Stimulating Catheter / 48 / At MINIMUM, the tray must have the following components: / One: 17 ga or 18 ga x 150mm Tuohy Needle, Stimulating / One: 20 ga x 24-39inl (61-100cm) Catheter / One: Catheter connector / f. 17 ga or 18 ga. x 40mm-50mm Nerve Block Continuous Kit - Stimulating Needle and NON-Stimulating Catheter / 946 / At MINIMUM, the tray must have the following components: / One: 17 ga or 18 ga x 40-50mm Tuohy Needle, Stimulating / One: 20 ga x 24inl-39inl (61-100cm) Catheter / One: Catheter connector / 6. Vendor must provide sterile Nerve Block Tray products and must provide documentation to support this upon initial submission. 7. Vendor must provide single-use Nerve Block Tray products and must provide documentation to support this upon initial submission. 8. Vendor must provide Nerve Block Trays not made from natural latex rubber and must provide documentation to support this upon initial submission. 9. Vendor must provide needle hubs that fit all luer lock and luer slip syringes and must provide documentation to support this upon initial submission. 10. Vendor must provide stimulating Nerve Block needles that have a fully insulated needle hub and shaft and must provide documentation to support this upon initial submission. 11. Vendor must provide stimulating Nerve Block needles with a conductive electrode area at the tip of the needle and must provide documentation to support this upon initial submission. 12. Vendor must provide Nerve Block needles with an ergonomically designed hub intended to improve handling of the needle and must provide documentation to support this upon initial submittal. 13. Vendor must provide Nerve Block needles that have 1cm depth markings and must provide documentation to support this upon initial submission. 14. Vendor must provide Nerve Block Needles that when used with appropriate adapter/connector, are compatible with a list of known manufacturer's nerve block stimulators: At a minimum, B. Braun, Sun Med, Neuro Technology, and Life-Tech, and provide documentation to support this upon initial submission. 15. Vendor must provide Nerve Block Trays that can be opened without contaminating the sterile contents within the tray. Evaluation After the lead MMESO receives all information required above, they will send each vendor making a complete and approved submission a written request to provide product samples to Clinical Product Team (CPT) members at the participating MTFs. MTF "Ship to" Addresses will be provided as part of the request. To ensure your eligibility to participate, all products required for evaluation must be shipped no later than 14 calendar days from issuance of the MMESO's request and must arrive at all designated MTFs no later than 5:00 PM local time at delivery location, 30 calendar days from issuance of the MMESO's request. Any products received beyond the stated date and time will not be included in the Clinical Process Teams' (CPT) reviews to establish the instant QSL and to participate in the subsequent Standardization Action, but will be destroyed upon receipt. Vendor will provide only the following products for evaluation. The products will be provided at no cost to the government for products or delivery, and unused products will not be returned. Six each of the required items listed is to be provided as product samples to each of the evaluation sites as requested by the Lead MMESO. Vendor will be required to supply the same part number(s) submitted in the QSL FBO Package Worksheet. Items for Evaluation Nerve Block Support Tray- Chronic Pain There will be approximately 5 MTFs enterprise-wide that will be evaluating products. Each evaluator will evaluate the vendor submissions in the Nerve Block Trays product line. The MMESO CPT will review the responses from the vendors and the results from the product evaluations and determine which vendors meet the requirements. A vendor who provides all requested information and meets the requirements will be selected for inclusion in the QSL. Vendors will be notified of whether they met or did not meet the QSL requirements by approximately October 2015. Points of Contact (POCs): Mr. Thomas Winkel, MMESO Europe Team Leader, thomas.p.winkel.ctr@mail.mil, 011-49-6371-9464-4089; and Ms. Gabrielle Burns, RN, BSN, MBA MMESO Europe Clinical Analyst, gabrielle.m.burns2.ctr@mail.mil, 011-49-6371-9464-4933. DLA Troop Support Medical Contracting Officer: Tara J. Perrien, tara.perrien@dla.mil (215) 737-8307.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/DLA/J3/DSCP-M/ME-1408-16/listing.html)
- Place of Performance
- Address: ERMC HQ, CMR 402 box 219, Dept G4, Bldg 3739, Rm 222, Landstuhl, Rhineland-Palatinate, Non-U.S., APO 09180-, Germany
- Record
- SN03719603-W 20150506/150504235251-7d8b5bd4a9a58a269e68756c41797fe5 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |